Compare Brevis (BREV) vs Symbiosis (SIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Symbiosis — how do they compare? Brevis trades at Rp1,189 (market cap Rp296,58M, Rp167,78M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Brevis is far larger — about 8.7× Symbiosis's market cap, and Brevis's circulating supply is 250M / 1B BREV (25%) versus 97M / 99,5M SIS (98%) for Symbiosis. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 8 Days and Symbiosis for 13 Days on average.
| BREV | SIS | |
|---|---|---|
Market Cap | Rp296,58M | Rp34,08M |
Volume (24h) | Rp167,78M | Rp2,71M |
Circulating Supply | 250M / 1B BREV (25%) | 97M / 99,5M SIS (98%) |
Typical Hold Time | 8 Days | 13 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Brevis (BREV) is trading at Rp1,215.88 with a market cap of Rp304.38 million, showing a bearish technical signal as moving averages indicate strong selling pressure while oscillators remain neutral. The current price sits just below the pivot point of Rp1,219, with immediate support at Rp1,203 and resistance at Rp1,237. No recent protocol updates or ecosystem news are available, and the token has a low circulation rate of 25% with a max supply of 1 million tokens.
Overall outlook is cautious due to bearish technicals and limited liquidity. Key opportunities include potential rebounds from oversold RSI levels, but major risks involve low trading volume, high volatility, and lack of recent development activity, making it susceptible to price swings.
Symbiosis (SIS) shows limited market activity with a modest market cap of Rp34.08M and high circulating supply utilization at 98%. The token exhibits a short average hold time of 13 days, suggesting active trading but potentially weak long-term holder confidence. No recent protocol updates or significant ecosystem developments have been recorded, indicating stagnant project momentum.
Overall outlook remains cautious due to low market cap and limited fundamental catalysts. Key opportunities include potential ecosystem growth if development resumes, while major risks involve low liquidity, high volatility typical of small-cap tokens, and regulatory uncertainty in the crypto space.
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Symbiosis
Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →
